• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

Danske Invest MediLife Fund

+ Add to Watchlist

MANMEDT:FH

692.28 EUR 0.000.00%

As of 01:59:30 ET on 11/24/2014.

Snapshot for Danske Invest MediLife Fund (MANMEDT)

Year To Date: +29.94% 3-Month: +10.97% 3-Year: +24.67% 52-Week Range: 510.24 - 692.28
1-Month: +4.71% 1-Year: +30.82% 5-Year: +15.93% Beta vs MXWO0PB: 0.99

Mutual Fund Chart for MANMEDT

No chart data available.
  • MANMEDT:FH 692.28
  • 1M
  • 1Y
Interactive MANMEDT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for MANMEDT

Danske Invest MediLife is an open-end fund registered in Finland. The Fund invests in pharmaceutical, biotechnology and medical technology and equipment companies worldwide. The Fund offers potential high yield, but also above average risk. The Fund's aim is to exceed the performance of the MSCI Pharmaceuticals -index \in the long term.

Inception Date: 08-15-2000 Telephone: 358-10-236-10
Managers: -
Web Site: www.danskeinvest.fi

Fundamentals for MANMEDT

NAV (on 2014-11-24) 692.28
Assets (M) (on 2014-10-31) 64.86
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 500.00

Dividends for MANMEDT

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-02) 0.02
Dividend Yield (ttm) 0.00

Fees & Expenses for MANMEDT

Front Load 1.00
Back Load 1.00
Current Mgmt Fee 1.95
Redemption Fee 1.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for MANMEDT

Filing Date: 08/29/2014
Name Position Value % of Total
Johnson & Johnson 38,335 3,015,233 5.094%
Gilead Sciences Inc 33,450 2,728,148 4.609%
Actavis plc 15,259 2,626,242 4.437%
Roche Holding AG 10,995 2,428,439 4.102%
Shire PLC 37,615 2,323,211 3.925%
HCA Holdings Inc 39,160 2,073,211 3.502%
Celgene Corp 26,920 1,939,595 3.277%
Puma Biotechnology Inc 9,645 1,905,231 3.219%
Salix Pharmaceuticals Ltd 15,225 1,836,859 3.103%
Boston Scientific Corp 182,355 1,753,307 2.962%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil